Evergreening - A controversial issue in pharma milieu

Journal of Intellectual Property Rights

Volumn 14, Issue 4, 2009, Pages 299-306

  Bansal, Inderjit Singh ^a   Sahu, Deeptymaya ^a   Bakshi, Gautam ^a   Singh, Sukhjeet ^a  

^a Panacea Biotec Ltd   (India)

Author keywords

Evergreening; Generics; Hatch Waxman Act; Market exclusivity; Paroxetine; Patent strategy; TRIPS agreement

Indexed keywords

EID: 77951812416     PISSN: 09717544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bakshi G, Pooja Singh S, Section 3 (d) of Indian Patent (Amendment) Act, 2005: A case perspective, Pharmabioworld, 7 (7) (2009) 16-22.
2. Temmerman, Michelangelo, The TRIPS Agreement, the Evergreening of Patents and Access to Medicines: Novartis v India (2008), 1-49.
3. Ragavan Srividhya, A patent restriction on research & development: Infringers or innovators? Journal of Law, Technology & Policy, 1(73) (2004) 73-98.
4. Anantharaman M G, Evergreening of patents, http://www. training.iprsupport jpo.jp/en/modules/smartsection/item.php? itemid=56.
5. Hunt M I, Prescription drugs and intellectual property protection, NTHCM Foundation, (2000) 1-12.
6. Schering v Geneva Pharmaceutical, 339 F3d 1373 (FCCA 2003).
7. Glover Gregory J, The influence of market exclusivity on drug availability and medical innovations, AAPS Journal, 9 (3) (2007) E312-316.
8. Andrade C, Shah N, Chandra S, The new patent regime: Implications for patients in India, Indian Journal of Psychiatry, 49 (1) (2007) 56-59.
9. GlaxoSmithkline briefings, (2007), (discussing evergreening and basic principles of the patent system), www.gsk.com/policies/GSK-and-evergreening.pdf.
10. Strongin Robin J, Hatch-Waxman, Generics, and Patents: Balancing Prescription Drug Innovation, Competition, and Affordability, NHPF Background paper, (2002)2-19.
11. Scott Hemphill C, Drug Patent Settlements between Rivals: A Survey, 2007, 1-49, http:// papers.ssrn.com/ so13/ papers. cfm?abstract-id= 969492.
12. Mylan Labs denies antitrust charges by FTC, http ://findarticles.com/p/ articles/mi-m3374/is-/ai-53617533.
13. Analysis of Mailbox Applications with special reference to Public Health, 2-110, http://www.whoindia.org/LinkFiles/Trade-Agreement-part2-annexure.pdf.
14. http://www.cafc.uscourts.gov/opinions/03-1285.pdf.
15. http://www.usdoj.gov/osg/briefs/2005/2pet/6invit/20050489.pet.ami.inv. pdf.
16. http://www.apotexcorp.com/press/Paxil-generic-04262004.htm.